Replies to post #211611 on Biotech Values

[DewDiligence]

SVRA—Six insiders bought a cumulative $1.1M of stock via the recent public offering at $4.75/sh (#msg-131865529):

https://www.sec.gov/Archives/edgar/data/1160308/000089924317015876/xslF345X03/doc4.xml
https://www.sec.gov/Archives/edgar/data/1032389/000089924317015872/xslF345X03/doc4.xml
https://www.sec.gov/Archives/edgar/data/1160308/000089924317015871/xslF345X03/doc4.xml
https://www.sec.gov/Archives/edgar/data/1160308/000089924317015868/xslF345X03/doc4.xml
https://www.sec.gov/Archives/edgar/data/1160308/000089924317015874/xslF345X03/doc4.xml
https://www.sec.gov/Archives/edgar/data/1160308/000089924317015869/xslF345X03/doc4.xml

[DewDiligence]

SVRA sells 4.89M* shares @$11.50—an 11% discount to yesterday’s close:

https://globenewswire.com/news-release/2018/07/26/1542785/0/en/Savara-Announces-Pricing-of-Public-Offering-of-Common-Stock.html

*Assuming exercise of underwriter’s option.